While the trial of 2016 Hillary Clinton campaign lawyer Michael Sussmann concluded with his acquittal, Special Counsel John Durham's prosecution team succeeded in revealing new evidence about how the false Trump-Russia collusion narrative got foisted upon the FBI and the nation.
Given that Marc Elias maintained all the emails were protected by attorney-client privilege, the court’s unquestioningly accepting his word seems strange.
Citing the "very serious constitutional questions" involved, U.S. Sen. Ron Johnson, R-Wis., has launched an investigation into the CDC's actions in tracking the cell phones of millions of Americans.
The head of the Department of Homeland Security’s Disinformation Governance Board has an extensive history of promoting baseless Trump-Russia collusion claims from Hillary Clinton’s 2016 presidential campaign, including allegations now scrutinized by special counsel John Durham.
CDC tracked "patterns of those visiting K-12 schools" as well as "visits to parks, gyms, or weight management businesses," according to CDC documents obtained via Freedom of Information Act request.
Hillary Clinton’s 2016 campaign, the DNC, Washington-based private intelligence firm Fusion GPS, and law firm Perkins Coie, Sussmann’s former employer, meanwhile, are trying to fend off Durham’s efforts to compel them to hand over previously withheld documents.
A group of former intelligence and national security officials on Monday issued a jointly signed letter warning that pending legislative attempts to restrict or break up the power of Big Tech monopolies — Facebook, Google, and Amazon — would jeopardize national security because, they argue, their centralized censorship power is crucial to advancing U.S. foreign policy.
The criminal prosecution of a Hillary Clinton campaign lawyer charged with lying to the FBI during the Trump-Russia investigation can move forward, a judge ruled Wednesday after denying a defense bid to dismiss the case.
As Big Tech and major retail firms move into healthcare they bring promises of convenience and innovation they claim will benefit consumers — but the move also raises questions about the ever-growing power and influence of such firms and their real motivation for getting into healthcare.
